Alto Neuroscience, Inc. · NYSE:ANRO

Smith Nicholas Conrad exercised options for 55,000 Alto Neuroscience, Inc. shares (Form 4)

Traded Oct 2, 2026 · Filed Oct 5, 2026

On Oct 2, 2026, Smith Nicholas Conrad (PRESIDENT AND CFO) exercised options for 55,000 Alto Neuroscience, Inc. shares at US$2.32 for US$128K, leaving 79,060 shares. Filed Oct 5, 2026 (Form 4).

Options exercised
55,000 shares
Price
US$2.32
Value
US$128K
Holding after
79,060 shares
Trading plan
No
Role
PRESIDENT AND CFO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 2, 2026Common StockOption exercise55,000US$2.3279,060Direct

Source

View original at SEC

Related